Study guide
3.1 Biochemistry and Systemic Physiology
Integrated National Board Dental Examination INBDE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: INBDE Exam Structure & Test Specifications
1.1 INBDE Format, Administration, Scoring & Retesting 1.2 The Domain of Dentistry: Test Specifications, Item Formats, Patient Boxes & Dental Charts
2 Chapter 2: Foundation Knowledge — Anatomic Sciences & Development
2.1 Gross & Head/Neck Anatomy and Histology 2.2 Oral Embryology, Tooth Development & Eruption 2.3 Genetic, Congenital & Developmental Conditions
3 Chapter 3: Foundation Knowledge — Biochemistry, Physiology & Physical Sciences
3.1 Biochemistry and Systemic Physiology 3.2 Physics & Chemistry of Oral Biology: pH, Diffusion & Demineralization
4 Chapter 4: Foundation Knowledge — Pathology, Microbiology & Immunology
4.1 General & Systemic Pathology 4.2 Microbiology, Immunology, and Infection Pathogenesis
5 Chapter 5: Foundation Knowledge — Pharmacology
5.1 Dental Pharmacology, Local Anesthetics, and Analgesics 5.2 Systemic Medications and Drug Interactions in Dentistry
6 Chapter 6: Foundation Knowledge — Dental Anatomy, Occlusion & Materials
6.1 Tooth Morphology, Anatomy, and Occlusion Biomechanics 6.2 Dental Materials Science, Biomaterials, and Impression Systems
7 Chapter 7: Patient Evaluation & Data Gathering
7.1 Chief Complaint, History Taking & Information from Diverse Sources 7.2 Comprehensive Patient History, Examination, and Medical Risk Assessment 7.3 Vital Signs, ASA Physical Status & Medical Risk Stratification 7.4 Normal Findings vs Significant Deviations Requiring Management
8 Chapter 8: Diagnostic Imaging
8.1 Dental Radiology Physics, Safety, and Imaging Interpretation 8.2 Intraoral Radiographic Technique, Errors & Quality Assurance 8.3 Radiographic Interpretation of Caries, Periapical & Bone Lesions 8.4 Panoramic, CBCT & Selection Criteria for Advanced Imaging
9 Chapter 9: Diagnostic Reasoning & Systemic Assessment
9.1 Diagnostic Testing, Laboratory Values, and Medical Complexities 9.2 Predictive Diagnostic Reasoning & Selecting the Right Diagnostic Test 9.3 Oral–Systemic Interrelationships 9.4 Differential Diagnosis of Orofacial Pain
10 Chapter 10: Oral Pathology & Mucosal Disease
10.1 Benign and Malignant Oral Pathology and Biopsy Protocols 10.2 Managing Oral Mucosal and Osseous Diseases
11 Chapter 11: Treatment Planning, Prognosis & Communication
11.1 Interdisciplinary Treatment Planning Sequencing and Prognosis 11.2 Prognosis Determination & Presenting Treatment Alternatives 11.3 Informed Consent, Refusal & Patient Education 11.4 Patient Attributes, Culture, Social Background & Care Across the Lifespan 11.5 Psychological, Social & Behavioral Principles in Patient Communication 11.6 Evaluating the Outcomes of Comprehensive Dental Care
12 Chapter 12: Medical & Dental Emergencies
12.1 Dental and Medical Emergencies in the Dental Office 12.2 Recognizing and Triaging Dental Emergencies
13 Chapter 13: Caries, Operative & Esthetic Dentistry
13.1 Caries Risk Assessment, Prevention, and Operative Dentistry 13.2 Adhesive Dentistry, Composite/Amalgam Restorations, and Esthetics 13.3 Managing the Esthetic Needs of Patients
14 Chapter 14: Endodontics
14.1 Pulpal Biology, Endodontic Diagnosis, and Emergency Treatment 14.2 Endodontic Therapy, Root Canal Instrumentation, Obturation, and Surgery
15 Chapter 15: Periodontics & Implantology
15.1 Periodontal Pathogenesis, Etiology, and Disease Classification 15.2 Non-Surgical Periodontal Therapy and Maintenance Protocols 15.3 Surgical Periodontics, Mucogingival Procedures, and Regenerative Care 15.4 Dental Implants: Planning, Surgical Placement, and Restorative Options
16 Chapter 16: Prosthodontics & Laboratory Communication
16.1 Fixed Prosthodontics: Crown/Bridge Preparation, Design, and Cementation 16.2 Removable Complete Dentures: Impression, Occlusion, and Delivery 16.3 Removable Partial Dentures: Components, Design, and Frameworks 16.4 Communicating Case Design to the Dental Laboratory
17 Chapter 17: Pain Control, Anesthesia & Oral Surgery
17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation 17.2 Dentoalveolar Surgery, Tooth Extraction, and Surgical Complications 17.3 Maxillofacial Trauma, Odontogenic Infections, and Complex Surgery
18 Chapter 18: Occlusion, TMD & Orthodontics
18.1 Craniofacial Growth, Development, and Orthodontic Diagnosis/Intervention 18.2 Developmental & Acquired Occlusal Problems 18.3 Temporomandibular Disorders: Diagnosis and Management
19 Chapter 19: Pediatric, Special Care & Vulnerable Patients
19.1 Pediatric Dental Care, Behavior Guidance, and Preventive Services 19.2 Pediatric Restorative Dentistry, Pulpal Therapy, and Dental Trauma 19.3 Special Care Dentistry: Geriatric, Special Needs, and Medically Compromised Patients 19.4 Recognizing, Managing & Reporting Patient Abuse and Neglect 19.5 Recognizing and Managing Substance Use Disorders
20 Chapter 20: Practice Management, Safety Systems & Informatics
20.1 Infection Control Protocols, Sterilization, and OSHA Compliance 20.2 Radiation Safety Guidelines, Dosimetry, and ALARA Principles 20.3 Practice Business Operations, OSHA & Regulatory Compliance 20.4 Catastrophe Preparedness & Practice Continuity Planning 20.5 Managing, Coordinating & Supervising Allied Dental Personnel 20.6 Quality Assurance, Assessment and Improvement 20.7 Dental Informatics, Electronic Records & Emerging Technology 20.8 Scope of Competence, Referral & Professional Self-Assessment
21 Chapter 21: Ethics, Jurisprudence, Evidence & Public Health
21.1 ADA Ethics Code, Jurisprudence, HIPAA, and Professional Conduct 21.2 Evidence-Based Dentistry, Clinical Epidemiology, and Dental Public Health 21.3 Biostatistics, Study Design & Critical Appraisal 21.4 Community Collaboration & Systems of Oral Health Care Delivery 21.5 Emerging Trends and Social/Economic Forces in Oral Health Care 21.6 Prevention, Intervention & Patient Education Strategies
3.1 Biochemistry and Systemic Physiology
Key Takeaways Explain This Topic AI
Hydroxylation of proline and lysine during intracellular collagen synthesis requires Ascorbic Acid (Vitamin C) and Fe2+ as essential cofactors; deficiency causes scurvy
Extracellular collagen cross-linking is mediated by Lysyl Oxidase, a copper-dependent enzyme
PTH increases serum Ca2+ and decreases serum PO43- (phosphaturic effect); Vitamin D increases BOTH serum Ca2+ and PO43-
Warfarin inhibits Vitamin K epoxide reductase (VKORC1), affecting Factors II, VII, IX, X; monitored by PT/INR (safe dental threshold <= 3.0-3.5)
Dental procedures in cardiac patients require limiting exogenous epinephrine to 0.04 mg (maximum 2 cartridges of 1:100,000 epinephrine)
Last updated: August 2026
- 1.2 Biochemistry and Systemic Physiology
- Collagen Biosynthesis, Maturation & Scurvy Pathogenesis
Collagen is the most abundant structural protein in the human body, serving as the principal organic matrix component of dentin, cementum, alveolar bone, periodontal ligament (PDL), and oral mucosa.
Step-by-Step Collagen Synthesis Pathway
Collagen processing involves a tightly regulated sequence of intracellular and extracellular post-translational modifications: INTRACELLULAR STEPS (Rough ER & Golgi):
- 1. Gene Transcription & Translation --> Preprocollagen
- 2. Signal Peptide Cleavage --> Procollagen alpha-chains
- 3. Hydroxylation of Proline & Lysine Residues (Requires Vitamin C + Fe2+)
- 4. Glycosylation of Hydroxylysine
- 5. Triple Helix Formation --> Procollagen Secretion into Extracellular Space
EXTRACELLULAR STEPS:
- 6. Cleavage of N- & C-Terminal Propeptides (by Procollagen Peptidases) --> Tropocollagen
- 7. Microfibril Alignment & Covalent Cross-linking (by Lysyl Oxidase [Requires Cu2+]) --> Mature Collagen Fiber
- Clinical Correlate: Scurvy (Vitamin C Deficiency)
Biochemical Defect : Ascorbic acid (Vitamin C) acts as a reducing agent to maintain iron in the ferrous (Fe2+) state required by prolyl hydroxylase and lysyl hydroxylase inside the rough endoplasmic reticulum.
Pathophysiology : Without Vitamin C, unhydroxylated procollagen alpha-chains cannot form stable triple helices and undergo rapid intracellular degradation at body temperature.
Oral & Systemic Manifestations : Defective collagen synthesis leads to capillary fragility (perifollicular hemorrhages, petechiae, ecchymoses), impaired wound healing, swollen/bleeding gingiva, and breakdown of the periodontal ligament leading to severe tooth mobility and loss.
Mineral Metabolism: Calcium, Phosphate & Hormonal Control
Serum calcium (normal: 8.5–10.5 mg/dL) and phosphate (normal: 2.5–4.5 mg/dL) concentrations are strictly regulated by three key hormones: Parathyroid Hormone (PTH) , Active Vitamin D (Calcitriol) , and Calcitonin .
Regulatory Parameter Parathyroid Hormone (PTH) Active Vitamin D (1,25-(OH)2D3) Calcitonin
Primary Source Chief cells of Parathyroid Glands Kidney Proximal Tubule (via 1-alpha-hydroxylase) Parafollicular C cells of Thyroid Gland
Trigger for Release Hypocalcemia (low serum Ca2+) Elevated PTH, Low serum PO43- Hypercalcemia (high serum Ca2+)
Effect on Bone Stimulates osteoclasts indirectly (via RANKL upregulation on osteoblasts) Increases bone resorption & mineralization Direct inhibition of osteoclasts
Effect on Kidney Increases Ca2+ reabsorption; decreases PO43- reabsorption Increases Ca2+ & PO43- reabsorption Decreases Ca2+ & PO43- reabsorption
Effect on Gut Indirectly increases absorption (via Vit D activation) Directly increases Ca2+ & PO43- absorption No direct effect
Net Serum Change Serum Ca2+ ↑ | Serum PO43- ↓ Serum Ca2+ ↑ | Serum PO43- ↑ Serum Ca2+ ↓ | Serum PO43- ↓
Exam Key Point: PTH has a phosphaturic effect (inhibits phosphate reabsorption in proximal tubule), whereas Vitamin D increases intestinal and renal absorption of BOTH calcium and phosphate.
Clinical Manifestations in Dentistry
Hyperparathyroidism : Excessive PTH production leads to subperiosteal bone resorption. Classic radiographic triad: generalized loss of the lamina dura , "ground-glass" trabecular pattern, and osteolytic lesion known as Brown Tumors of Hyperparathyroidism (osteitis fibrosa cystica).
Rickets (Children) / Osteomalacia (Adults) : Vitamin D deficiency resulting in unmineralized osteoid matrix. Dental features: Delayed eruption, enamel hypoplasia, and wide pulp chambers with prominent interglobular dentin.
Blood Coagulation Cascade & Anticoagulant Pharmacotherapy
Hemostasis occurs in two phases: Primary Hemostasis (vascular spasm and platelet plug formation) and Secondary Hemostasis (coagulation cascade generating a stable fibrin clot). INTRINSIC PATHWAY (Monitored by aPTT) EXTRINSIC PATHWAY (Monitored by PT/INR)
- Surface Contact (Subendothelial Collagen) Tissue Factor (Factor III) + Factor VIIa
- ↓ ↓
- Factors XII → XI → IX + VIIIa (Tenase) ↓
- └──────────────────────────┬─────────────────────────┘
- ↓
- COMMON PATHWAY (Factor X)
- ↓
- Factor Xa + Va (Prothrombinase)
- ↓
- Prothrombin (II) → Thrombin (IIa)
- ↓
- Fibrinogen (I) → Fibrin Monomer (Ia)
- ↓
- Factor XIIIa Cross-links Fibrin Clot
- Coagulation Pathways & Laboratory Assessment
Extrinsic Pathway : Triggered by tissue injury releasing Tissue Factor (Factor III), activating Factor VII . Assessed by Prothrombin Time (PT) and International Normalized Ratio (INR) . Normal INR = 0.8–1.1.
Intrinsic Pathway : Triggered by subendothelial collagen contact, activating Factors XII, XI, IX, and VIII . Assessed by Activated Partial Thromboplastin Time (aPTT) . Normal aPTT = 25–35 seconds.
Common Pathway : Factor X activation → converts Prothrombin (II) to Thrombin (IIa) → converts Fibrinogen (I) to Fibrin (Ia) → cross-linked by Factor XIIIa.
Anticoagulation Pharmacology & Dental Management
Warfarin (Coumadin) : Inhibits Vitamin K epoxide reductase (VKORC1) , preventing hepatic synthesis of functional Factors II, VII, IX, X, and Proteins C and S . Monitored via PT/INR.
Dental Guideline : Minor oral surgery (extractions, periodontal surgery) can be performed safely when INR is <= 3.0 to 3.5 . Warfarin should NOT be routinely discontinued prior to dental procedures due to high risk of thromboembolism. Local hemostatic agents (gelfoam, oxidized cellulose, sutures, tranexamic acid rinse) are utilized.
Direct Oral Anticoagulants (DOACs) : Direct Factor Xa inhibitors (Rivaroxaban, Apixaban) and Direct Thrombin inhibitors (Dabigatran). Do not require routine INR monitoring.
Heparin : Enhances Antithrombin III activity, inactivating Thrombin and Factor Xa. Monitored via aPTT. Reversed by Protamine Sulfate .
Inherited Coagulopathies :
Hemophilia A : Deficiency of Factor VIII (X-linked recessive; prolonged aPTT, normal PT/INR & bleeding time).
Hemophilia B (Christmas Disease) : Deficiency of Factor IX (X-linked recessive; prolonged aPTT).
Von Willebrand Disease (vWD) : Deficiency/defect in vWF (Autosomal dominant). Impairs platelet adhesion (prolongs Bleeding Time) and destabilizes Factor VIII (prolongs aPTT).
- Cardiovascular Physiology & Dental Considerations
- Blood Pressure Regulation & Cardiac Mechanics
Cardiac Output (CO) = Stroke Volume (SV) × Heart Rate (HR). Stroke volume is governed by Preload (end-diastolic volume), Afterload (systemic vascular resistance), and Contractility.
Short-Term BP Control : Baroreceptor Reflex . Baroreceptors in the carotid sinus (sensory via CN IX ) and aortic arch (sensory via CN X ) detect stretch changes and rapidly alter autonomic outflow.
Long-Term BP Control : Renin-Angiotensin-Aldosterone System (RAAS) . Decreased renal perfusion triggers Juxtaglomerular (JG) cells to release Renin → converts Angiotensinogen to Angiotensin I → converted by endothelial ACE (lung) to Angiotensin II (potent vasoconstrictor and stimulator of Aldosterone release from adrenal cortex).
Heart Failure (HF) & Cardiac Epinephrine Limits
Left-Sided Heart Failure : Inability of left ventricle to pump blood, causing backup into pulmonary circulation. Manifests as exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea , pulmonary edema, and bibasilar crackles.
Right-Sided Heart Failure : Inability of right ventricle to pump blood to lungs, causing systemic venous congestion. Manifests as peripheral pitting edema, jugular venous distension (JVD) , and hepatomegaly. Most common cause is left-sided HF.
Dental Management Guidelines :
Position HF patients semi-supine or upright to prevent pulmonary congestion and orthopnea.
Cardiac Epinephrine Dose Limit : For patients with significant cardiovascular disease or hypertension, limit exogenous epinephrine to 0.04 mg per appointment (maximum 2 cartridges of 1:100,000 epinephrine or 4 cartridges of 1:200,000 epinephrine).
Renal Physiology & Fluid/Electrolyte Balance
Each kidney contains ~1 million functional units called nephrons responsible for filtration, reabsorption, and secretion. Nephron Segment Functional Summary:
- Proximal Convoluted Tubule (PCT) --> Reabsorbs 65-70% Na+, H2O, HCO3-, 100% Glucose/Amino Acids
- Loop of Henle (Thick Ascending) --> NKCC2 Transporter (Reabsorbs Na+/K+/2Cl-); Site of Loop Diuretics
- Distal Convoluted Tubule (DCT) --> NCC Transporter (Na+/Cl-); PTH increases Ca2+ reabsorption; Thiazides
- Collecting Duct --> Principal Cells (Na+/H2O reabsorption via Aldosterone & ADH)
- Intercalated Cells (H+ secretion & Acid-Base balance)
Proximal Convoluted Tubule (PCT) : Bulk reabsorption zone. Reabsorbs ~65–70% of filtered Na+ and water, along with 100% of filtered glucose and amino acids (via Na+-coupled secondary active transport).
Loop of Henle : Creates hyperosmotic medullary gradient. The thick ascending limb actively reabsorbs Na+, K+, and 2Cl- via the NKCC2 cotransporter (inhibited by Loop Diuretics like Furosemide). Impermeable to water.
Distal Convoluted Tubule (DCT) : Reabsorbs Na+ and Cl- via the NCC cotransporter (inhibited by Thiazide Diuretics ). Site of active Ca2+ reabsorption stimulated by PTH .
Collecting Duct : Target for hormonal control:
Aldosterone : Acts on Principal Cells to upregulate luminal ENaC channels and basolateral Na+/K+-ATPase, promoting Na+ and water reabsorption and K+/H+ secretion .
Antidiuretic Hormone (ADH / Vasopressin) : Binds V2 receptors on Principal Cells to insert Aquaporin-2 water channels, producing concentrated urine.